EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 41 / No 11 (Novembre 2025) Med Sci (Paris), 41 11 (2025) 855-859 References
Open Access
Issue
Med Sci (Paris)
Volume 41, Number 11, Novembre 2025
Page(s) 855 - 859
Section Nouvelles
DOI https://doi.org/10.1051/medsci/2025216
Published online 12 December 2025
  1. Christo SN, Park SL, Mueller SN, et al. The multifaceted role of tissue-resident memory T cells. Annu Rev Immunol 2024 ; 42 : 317-45. [Google Scholar]
  2. Damei I, Trickovic T, Mami-Chouaib F, et al. Tumor-resident memory T cells as a biomarker of the response to cancer immunotherapy. Front Immunol 2023 ; 14 : 1205984. [Google Scholar]
  3. Milner JJ, Toma C, He Z, et al. Heterogenous populations of tissue-resident CD8+ T cells are generated in response to infection and malignancy. Immunity 2020 ; 52 : 808-24.e7. [Google Scholar]
  4. Park SL, Christo SN, Wells AC, et al. Divergent molecular networks program functionally distinct CD8+ skin-resident memory T cells. Science 2023 ; 382 : 1073-9. [Google Scholar]
  5. Paolini L, Tran T, Corgnac S, et al. Differential predictive value of resident memory CD8+ T cell subpopulations in patients with non-small-cell lung cancer treated by immunotherapy. J Immunother Cancer 2024 ; 12 : e009440. [Google Scholar]
  6. Reilly EC, Sportiello M, Emo KL, et al. CD49a identifies polyfunctional memory CD8 T cell subsets that persist in the lungs after influenza infection. Front Immunol 2021 ; 12 : 728669. [Google Scholar]
  7. Benhamouda N, Sam I, Epaillard N, et al. Plasma CD27, a surrogate of the intratumoral CD27–CD70 interaction, correlates with immunotherapy resistance in renal cell carcinoma. Clin Cancer Res 2022 ; 28 : 4983-94. [Google Scholar]
  8. Sam I, Benhamouda N, Biard L, et al. Soluble CD27 differentially predicts resistance to anti-PD1 alone but not with anti-CTLA-4 in melanoma. EMBO Mol Med 2025 ; 17 : 909-22. [Google Scholar]
  9. Sam I, Ben Hamouda N, Alkatrib M, et al. The CD70-CD27 axis in cancer immunotherapy: Predictive biomarker and therapeutic target. Clin Cancer Res 2025 ; 31 : 2872-81. [Google Scholar]
  10. Cheuk S, Schlums H, Gallais Sérézal I, et al. CD49a expression defines tissue-resident CD8+ T cells poised for cytotoxic function in human skin. Immunity 2017 ; 46 : 287-300. [Google Scholar]
  11. Obers A, Poch T, Rodrigues G, et al. Retinoic acid and TGF-β orchestrate organ-specific programs of tissue residency. Immunity 2024 ; 57 : 2615-33.e10. [Google Scholar]
  12. Murray T, Fuertes Marraco SA, Baumgaertner P, et al. Very late antigen-1 marks functional tumor-resident CD8 T cells and correlates with survival of melanoma patients. Front Immunol 2016 ; 7 . [Google Scholar]
  13. Sandoval F, Terme M, Nizard M, et al. Mucosal imprinting of vaccine-induced CD8+ T cells is crucial to inhibit the growth of mucosal tumors. Sci Transl Med 2013 ; 5. [Google Scholar]
  14. Nizard M, Roussel H, Diniz MO, et al. Induction of resident memory T cells enhances the efficacy of cancer vaccine. Nat Commun 2017 ; 8 : 15221. [Google Scholar]
  15. Künzli M, O’Flanagan SD, LaRue M, et al. Route of self-amplifying mRNA vaccination modulates the establishment of pulmonary resident memory CD8 and CD4 T cells. Sci Immunol 2022 ; 7 : eadd3075. [Google Scholar]
  16. Abdeljaoued S, Doussot A, Kroemer M, et al. Liver metastases of colorectal cancer contain different subsets of tissue-resident memory CD8 T cells correlated with a distinct risk of relapse following surgery. OncoImmunology 2025 ; 14 : 2455176. [Google Scholar]
  17. Luoma AM, Suo S, Wang Y, et al. Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy. Cell 2022 ; 185 : 2918-35.e29. [Google Scholar]
  18. Lee YJ, Kim JY, Jeon SH, et al. CD39+ tissue-resident memory CD8+ T cells with a clonal overlap across compartments mediate antitumor immunity in breast cancer. Sci Immunol 2022 ; 7 : eabn8390. [Google Scholar]
  19. Pai JA, Hellmann MD, Sauter JL, et al. Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade. Cancer Cell 2023 ; 41 : 776-90.e7. [Google Scholar]
  20. Nagasaki J, Inozume T, Sax N, et al. PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes. Cell Rep 2022 ; 38 : 110331. [CrossRef] [PubMed] [Google Scholar]
  21. Connolly KA, Kuchroo M, Venkat A, et al. A reservoir of stem-like CD8+ T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response. Sci Immunol 2021 ; 6 : eabg7836. [Google Scholar]
  22. Burger ML, Cruz AM, Crossland GE, et al. Antigen dominance hierarchies shape TCF1+ progenitor CD8 T cell phenotypes in tumors. Cell 2021 ; 184 : 4996-5014.e26. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.